Difficulty: Medium
Average Score: 95%
Practice
The compound most likely to lower circulating leukotriene levels is
Correct answer
A
Rationale
The correct answer is A) Zileuton. Zileuton is a 5-lipoxygenase inhibitor that works by blocking the enzyme responsible for the formation of leukotrienes, which are inflammatory mediators involved in various allergic and inflammatory conditions. By inhibiting 5-lipoxygenase, zileuton effectively lowers circulating leukotriene levels, making it an effective treatment for conditions such as asthma.
Option B) Montelukast is a leukotriene receptor antagonist, which means it works by blocking the action of leukotrienes at specific receptors rather than reducing their production like Zileuton. While Montelukast can help manage conditions like asthma by preventing leukotrienes from binding to receptors, it does not directly lower circulating leukotriene levels like Zileuton.
Option C) Carprofen is a nonsteroidal anti-inflammatory drug (NSAID) commonly used in veterinary medicine to relieve pain and inflammation in conditions like osteoarthritis in dogs. It works mainly by inhibiting the enzyme cyclooxygenase (COX) and has no direct effect on leukotriene levels.
Option D) Aspirin is also an NSAID but primarily inhibits the enzyme COX to reduce the production of prostaglandins, another type of inflammatory mediator. Aspirin does not target leukotriene synthesis and therefore does not lower circulating leukotriene levels.
In an educational context, understanding the mechanisms of action of different drugs is crucial for healthcare professionals to make informed decisions regarding drug selection and treatment strategies. Knowing how specific drugs like Zileuton target the production of leukotrienes can help clinicians optimize therapy for patients with conditions where leukotrienes play a significant role, such as asthma or allergic rhinitis.
Option B) Montelukast is a leukotriene receptor antagonist, which means it works by blocking the action of leukotrienes at specific receptors rather than reducing their production like Zileuton. While Montelukast can help manage conditions like asthma by preventing leukotrienes from binding to receptors, it does not directly lower circulating leukotriene levels like Zileuton.
Option C) Carprofen is a nonsteroidal anti-inflammatory drug (NSAID) commonly used in veterinary medicine to relieve pain and inflammation in conditions like osteoarthritis in dogs. It works mainly by inhibiting the enzyme cyclooxygenase (COX) and has no direct effect on leukotriene levels.
Option D) Aspirin is also an NSAID but primarily inhibits the enzyme COX to reduce the production of prostaglandins, another type of inflammatory mediator. Aspirin does not target leukotriene synthesis and therefore does not lower circulating leukotriene levels.
In an educational context, understanding the mechanisms of action of different drugs is crucial for healthcare professionals to make informed decisions regarding drug selection and treatment strategies. Knowing how specific drugs like Zileuton target the production of leukotrienes can help clinicians optimize therapy for patients with conditions where leukotrienes play a significant role, such as asthma or allergic rhinitis.